alexa Haval Shirwan
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Haval Shirwan

 Institute for Cellular Therapeutics, Department of Microbiology and Immunology, University of Louisville, Louisville, KY, 40202, USA

 Dr. Shirwan is the Dr. Michael and Joan Hamilton Endowed Chair in Autoimmune Disease and a Professor in the Department of Microbiology and Immunology at the University of Louisville, and Director of the Molecular Immunomodulation Program at the Institute for Cellular Therapeutics at UofL. Dr. Shirwan has served on numerous study sections for national and international funding agencies, including the National Institutes of Health, the Veteran's Administration, The U.S.-Israel Binational Science Foundation, Israel Science Foundation, American Heart Association, Wellcome Trust, and Philip Morris USA Inc. He has also served on the Editorial Board of the journal Graft, was Section Editor for Current Opinion in Organ Transplantation, and an ad hoc reviewer for numerous scientific journals. He is the member of several scientific organizations and authored more than 100 papers, reviews, and book chapters.. Dr. Shirwan's numerous honors and recognitions include the following organizations and awards: the North Atlantic Treaty Organization, the Red Cross, an NIH First Independent Research Support & Transition (FIRST) award, the American Society of Transplant Physicians-Ortho Award, the Cedars-Sinai Medical Center Young Investigator Award, and the Louisville Business First, Partners in Health Care Award.

Research Interest

 Immunology, Immunomodulation, Immune gene therapy, Transplantation immunology


The Promise of PD-1 Signaling Pathway for Cancer Immunotherapy

Rajesh Kumar Sharma, Esma S. Yolcu, and Haval Shirwan

Editorial: J Clin Cell Immunol 2012, 3: e110

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version